“两票制”下药品流通企业的发展方向探讨  

Discussion on the Development Direction of Drug Circulation Enterprises under “Two Invoice System”

作　　者：张宇波 陈阳[1] 孙可心 黄莉[3] ZHANG Yubo;CHEN Yang;SUN Kexin;HUANG Li(School of Public Health and Management,Chongqing Medical University,Chongqing 400016,China;The Second Clinical College,Chongqing Medical University,Chongqing 400016,China;Personnel Division,the First Affiliated Hospital of Chongqing Medical University,Chongqing 404000,China)

机构地区：[1]重庆医科大学公共卫生与管理学院,重庆400016 [2]重庆医科大学第二临床学院,重庆400016 [3]重庆医科大学附属第一医院人事处,重庆404000

出　　处：《中国药房》2018年第5期577-579,共3页China Pharmacy

基　　金：重庆市社会科学规划项目(No.2015YBGL108)

摘　　要：目的:为"两票制"下药品流通企业的发展提供建议。方法:通过分析"多票制"对药品流通企业的消极影响和"两票制"对药品流通企业的积极影响,探讨"两票制"下药品流通企业的发展方向。结果与结论:"多票制"使得药品价格居高不下,造成药品流通成本高、药品质量难把关。"两票制"则规范了药品流通领域的秩序,节约了医疗药品资源,降低了药品价格,稳固了资金链条。"两票制"下药品流通企业应积极适应医药市场转型、重构药品流通链条,相关部门及各主体之间应建立医药流通网络一体化,药品流通主体要促进票、账、货核对工作,规范回账日期,稳步实施改革。OBJECTIVE:To provide suggestions for the development of drug circulation enterprises under“two invoice system”.METHODS:By analyzing the negative effects of“multi invoice system”on drug circulation enterprises and positive effects of“two invoice system”on drug circulation enterprises,the development direction of drug circulation enterprises was investigated under“two invoice system”.RESULTS&CONCLUSIONS:The“multi invoice system”formulates the high drug price,causes high drug circulation cost and is difficult to check drug quality.The“two invoice system”standardizes the order of drug circulation field,saves medical drug source,reduce drug price and kept capital chain stable.Under“two invoice system”,drug circulation enterprises should actively adapt to the transformation of medical and pharmaceutical market,and reconstruct the chain of drug circulation.The integration of medical circulation network should be established between the relevant departments and various subjects.Drug circulation subjects should promote the check of ticket,account and goods,standardize the date of back account,implement reform stably.

关 键 词：“两票制” 药品流通企业 发展方向 

分 类 号：R-012[医药卫生]